IP Library Granted Patent US 7,758,883
Granted Patent B2
US 7,758,883 · App. 10/688,539 · Granted Jul 20, 2010

Three layer artificial tear formulation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,758,883
App. No.
10/688,539
Granted
Jul 20, 2010
Kind
B2
Abstract

An artificial tear film over the surface of an eye having a first layer in direct contact with the ocular surface, an aqueous layer over the first layer, and a layer of a phospholipid over the aqueous layer. The first layer has polyvinyl alcohol, polyvinyl acetate, and polyvinyl pyrrolidone. The phospholipid is derived from Amisol® Clear. The artificial tear film is effective in significantly prolonging the tear break up time in patients with dry eye syndrome.

Claims (8)

1. A composition for ophthalmic use, comprising:

a) polyvinyl alcohol, wherein the concentration of said polyvinyl alcohol is from about 0.5% to 10% by weight in water, said polyvinyl alcohol being about 96% to 99% hydrolyzed;

b) polyvinyl acetate, wherein the concentration of said polyvinyl acetate is from about 0.5% to 10% by weight in water, said polyvinyl acetate being about 73% to 93% hydrolyzed;

c) polyvinyl pyrrolidone, wherein the concentration of said polyvinyl pyrrolidone is from about 0.5% to 10% by weight in water; and

d) a phospholipid, wherein the concentration of said phospholipid is from about 0.003% to 0.02% by weight in water.

2. The composition of claim 1 wherein said phospholipid is formulated in polysorbate-80, glycerin, ethanol, and water.

3. The composition of claim 1 wherein said phospholipid is lecithin.

4. The composition of claim 1 further comprising water, one or more electrolytes to contribute to the well being of the corneal epithelium, one or more preservatives, and one or more buffers.

Assignments (8)
SECURITY INTEREST Recorded Sep 26, 2025
From: HARROW, INC.; HARROW IP, LLC
To: FIFTH THIRD BANK, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 072384/0781 →
RELEASE OF SECURITY INTEREST Recorded Sep 17, 2025
From: OAKTREE FUND ADMINISTRATION, LLC, AS ADMINISTRATIVE AGENT
To: HARROW IP, LLC
Reel/Frame 072280/0573 →
SUPPLEMENTAL PATENT SECURITY AGREEMENT (FIRST SUPPLEMENTAL FILING) Recorded Aug 18, 2023
From: HARROW IP, LLC
To: OAKTREE FUND ADMINISTRATION, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 064640/0535 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 2, 2023
From: EYEVANCE PHARMACEUTICALS LLC
To: HARROW IP, LLC
Reel/Frame 064468/0450 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Oct 9, 2020
From: HAYFIN SERVICES LLP
To: EYEVANCE PHARMACEUTICALS LLC
Reel/Frame 054172/0632 →
SECURITY INTEREST Recorded Oct 17, 2019
From: EYEVANCE PHARMACEUTICALS LLC, AS GRANTOR
To: HAYFIN SERVICES LLP, AS COLLATERAL AGENT
Reel/Frame 050751/0051 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2018
From: FOCUS LABORATORIES, INC.
To: EYEVANCE PHARMACEUTICALS LLC
Reel/Frame 047677/0824 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2018
From: AQUEOUS PHARMA LIMITED
To: FOCUS LABORATORIES, INC.
Reel/Frame 046293/0160 →